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finding was made that significantly fewer patients received ECGs
during the changeover period (Group 3), with only 6/18 (33%) of
patients receiving ECGs. The percentage of patients who were not
offered ECGs also increased during the changeover period, with
2/50 (4%) in Group 1, and 3/18 (17%) in Group 3 not being
offered.
Conclusion. This incidental finding highlights the challenges
associated with the junior doctor changeover period. Much time
is needed for doctors to adjust to their new surroundings and
methods of working, and this may result in basic elements of
patient care being overlooked. We surmise that other elements,
such as ensuring all patients having regular blood tests and phys-
ical examinations, may also be of a lower standard during this
period. There is scope for future audits to address this, and for
future quality improvement projects to implement changes ensur-
ing medical care remains at a high standard during junior doctor
changeover periods.
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Aims. Growing evidence suggests vitamin D as a contributing fac-
tor in psychiatric illness, particularly depression. Leeds and York
Partnership NHS Foundation Trust (LYPFT) has a policy recom-
mending that vitamin D levels are checked in all inpatients. The
principal aims of this audit were to establish whether vitamin D
levels were checked in inpatients and whether oral supplementa-
tion was commenced where appropriate, with a pre-determined
target of 90% for both. The secondary aims were to assess whether
rates of checking and replacing vitamin D, and mean vitamin D
levels, differed between Caucasian and non-Caucasian
populations.
Method. We investigated adults aged 18–65 years newly admitted
to the Becklin Centre, an acute psychiatric inpatient unit of four
wards, between 1st December 2019 and 29th February 2020.
140 patients met eligibility criteria and were included in this
study, of which 86 (61.4%) were Caucasian. Data were collected
between 25th and 28th February 2021 by retrospectively reviewing
two electronic patient record systems, Care Director and
PPM, and the electronic prescribing platform EPMA. Results
were compiled on a pre-determined data collection tool and ana-
lysed using Microsoft Excel. We defined insufficiency as serum
25-hydroxyvitamin D levels below 75nmol/l and deficiency as
below 30nmol/l.
Result. Vitamin D levels were checked in 79 (56.4%) inpatients,
and the proportion checked differed significantly according to
ethnicity (Caucasian = 64.0%, non-Caucasian = 44.4%; χ2 =
4.59, p = 0.032). Of these, 1 (1.3%) had an insufficient sample, 5
(6.3%) had normal levels, 41 (51.9%) had insufficient levels and
32 (40.5%) were deficient. Colecalciferol was commenced for 61
(83.6%) of those with insufficient or deficient vitamin D levels.
Rates of colecalciferol prescribing did not differ between ethnic
groups (Caucasian = 82.0%, non-Caucasian = 85.0%; χ2 = 0.091,
p = 0.76). Mean vitamin D levels did not significantly differ
(p = 0.77) between Caucasians (38.3nmol/l) and non-Caucasians
(36.2nmol/l).
Conclusion. LYPFT did not meet the target for testing for and
treating vitamin D insufficiency and deficiency in psychiatric
inpatients. Other blood results were often available when vitamin
D levels were not, suggesting a lack of awareness of the guidance.
Ethnicity influenced rates of vitamin D analysis but not replace-
ment or mean serum levels. We aim to present our findings to
the Trust’s medical workforce to raise awareness of the relevant
guidance. Given the paucity of psychiatric inpatients with normal
vitamin D levels, further research into the role of vitamin D in
psychopathology is warranted.
Clinical audit investigating the recognition of tardive
dyskinesia in an acute inpatient setting
Daniel Romeu1*, Christiana Elisha-Aboh2, Hamza Abid2,
Lauren Merry3, Tariq Mahmood2 and Fiona Lacey2
1Leeds and York Partnership NHS Foundation Trust, Leeds Institute
of Health Sciences, University of Leeds; 2Leeds and York Partnership
NHS Foundation Trust and 3Leeds Teaching Hospitals NHS Trust
*Corresponding author.
doi: 10.1192/bjo.2021.303
Aims. Tardive dyskinesia (TD) is a disabling extra-pyramidal side
effect (EPSE) associated with long-term antipsychotic medication,
with an incidence rate of 5% per year of typical antipsychotic
exposure. The Abnormal Involuntary Movement Scale (AIMS)
is a validated tool for screening for TD and its use is recom-
mended every 3–6 months in those taking antipsychotics.
Atypical antipsychotics present a lower risk and have contributed
to complacency in monitoring and treatment. The primary aim of
this audit was to establish whether AIMS was completed for all
patients taking regular antipsychotic medication for three months
or more. Secondary aims were to investigate whether patients were
informed about EPSEs on initiation, titration and change of anti-
psychotics, and whether they were assessed for the emergence of
side effects during subsequent clinical reviews.
Method. This single-site audit examined the care of inpatients on
Ward 4 of the Becklin Centre, a male working-age acute psychiatric
ward, between 1st November 2020 and 31st January 2021. Patients
aged 18–65 years who were prescribed regular antipsychotics were
eligible for inclusion. Exclusion criteria included the presence of
other neurological movement disorders. 50 patients were included.
Data collection took place between 8th February and 6th March
2021; this involved reviewing patient records throughout their
inpatient stay on Care Director, an electronic patient record system.
Results were compiled using a pre-determined data collection tool
and analysed using Microsoft Excel.
Result. For 14 (28.0%) patients there was documented evidence of
the provision of verbal information surrounding EPSEs during
initiation or change of antipsychotics, and 12 (24.0%) received
written or verbal information about wider side effects. For 19
(38.0%) there was a documented assessment of side effects during
clinical review following the initiation or change of antipsychotic
medication. Of the 33 patients who took antipsychotics for over
three months, 3 (9.1%) received an AIMS assessment.
Conclusion. An inadequate proportion of inpatients prescribed
long-term antipsychotics were assessed for TD, likely due to a
lack of awareness of the relevant guidance. A substantial number
of patients were not informed about side effects, suggesting an
element of medical paternalism. This study provides opportunity
to improve practice by educating the medical workforce and rais-
ing awareness of TD symptoms amongst the wider team.
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